ABSTRACT SUBMISSION

DEADLINE FOR SUBMITTING ABSTRACT: April 22, 2026

The online abstract system will be closed after this date.

THE TOP 3 PAPERS WILL BE AWARDED.

Click the "Submit Online Abstract" button…

 

ABSTRACT SUBMISSION AND EVALUATION

Abstracts must be submitted online via the congress submission system only and will be evaluated by the Scientific Review Committee. Abstracts submitted by e-mail or through any other means will not be considered.

Abstract presentations by undergraduate students are not accepted within the scope of the congress.

Each participant may submit and present more than one abstract.

To present an accepted abstract, the presenting author must complete congress registration by the end of the early registration period at the latest. In multi-author submissions, co-authors are also required to register if they wish to attend the congress.

All accepted abstracts will be published in the Hacettepe University Journal of the Faculty of Pharmacy (HUJPHARM), which is indexed in Scopus.
Authors are fully responsible for spelling, grammar, and formatting errors.

After completion of the evaluation process, no revisions or modifications will be allowed through the system.

Abstracts will be reviewed under a double-blind review process, with all personal and institutional information kept confidential. Evaluation results will be communicated to the presenting author via e-mail and may also be followed through the submission system. Informing co-authors of the acceptance or rejection decision is the responsibility of the presenting author.

GENERAL INFORMATION

Abstracts may be submitted in the following categories: Drug design and discovery / Structure-activity relationship (sar), quantitative structure-activity relationship (qsar) and molecular modeling studies / Pharmacokinetics, pharmacodynamics, and admet profiling / Advances in organic and medicinal chemistry / Synthesis of new bioactive molecules / Stereochemistry in drug design and discovery / Drug development with natural products and phytochemistry / Biotransformation and metabolism of drug molecules / Pharmacology of molecular drug targets / Analytical techniques in medicinal chemistry: pharmaceutical analysis and validation / New strategies and emerging approaches in medicinal chemistry / Types of Vaccines / Contributions of Vaccines to Human Life and Health / Anatomy and Chemistry of Vaccines / Vaccination in Türkiye / Immunization Laws

Authors must select one of the following abstract types: Research Study or Case Report.

During submission, authors should indicate their preferred presentation type (Poster, short oral presentation or Oral Presentation); however, the Scientific Committee reserves the right to change the presentation format.

The official language of the congress is English, and all abstracts must be submitted in English.

The abstract text is limited to 300 words, excluding the Title, Author(s), Institution(s), Keywords and tables. The system will not accept abstracts exceeding this limit.

Abstracts must be structured as follows: Title, Author(s), Institution(s), Abstract Text, and Keywords. Detailed formatting rules for titles, author names, and institutions are provided in the online submission system. Academic titles and full postal addresses should not be included.

For Research Studies, abstracts must include the following sections: Introduction, Materials and Methods, Results and Conclusion (for ongoing studies, expected outcomes may be stated), followed by Keywords.

For Case Reports, a structured format is not mandatory; however, the aim and scope of the case must be clearly described.

Abbreviations used in the abstract must be defined at first mention.

Abstracts that do not comply with the submission guidelines will not be evaluated.